🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to compare the efficacy of three therapies for chronic obst...
Status
Unknown
Location
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Start Date
2017-05
Trial ID
NCT03169504
Treatments Being Tested
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2018-11-20
Trial ID
NCT03751202
Treatments Being Tested
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
This trial is a randomized, double-blind, parallel-group, multicenter study...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04-30
Trial ID
NCT01110200
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2020-09-22
Trial ID
NCT04564456
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-13
Trial ID
NCT02924688
This is a multi-centre, randomised, double-blind, double-dummy, two way cro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-14
Trial ID
NCT01978145
The purpose of this study is to compare the effectiveness and safety of ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01555138
Treatments Being Tested